
Inpharmus Expands Global Reach in Rare Diseases and Oncology
Inpharmus is steadily increasing its presence in global healthcare by using its strong knowledge of rare diseases and cancer treatments, along with a team of
Inpharmus is steadily increasing its presence in global healthcare by using its strong knowledge of rare diseases and cancer treatments, along with a team of
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, shared the following update related to ELEVIDYS, the only approved gene therapy for patients